Cross-cultural adaptation and validation of the International Cooperative Ataxia Rating Scale (ICARS) to Brazilian Portuguese

ABSTRACT

Introduction: The clinical assessment of patients with ataxias requires reliable scales. We aimed to translate, adapt and validate the International Cooperative Ataxia Rating Scale (ICARS) into Brazilian Portuguese.

Methods: The steps of this study were forward translation, translation synthesis, backward translation, expert committee meeting, preliminary pilot testing and final assessment. Thirty patients were enrolled in the preliminary pilot testing and 61 patients were evaluated for construct validity, internal consistency, intra- and inter-rater reliability and external consistency.

Results: This study showed good validity of the construct and high internal consistency for the full scale, except for the oculomotor domain (Cronbach's alpha = 0.316, intraclass correlation coefficients intra- = 82.4% and inter- = 79.2%). A high correlation with the Scale for the Assessment and Rating of Ataxia was observed. We found good intra-rater agreement and relative inter-rater disagreement, except in the posture and gait domain.

Conclusion: The present ICARS version is adapted for the Brazilian culture and can be used to assess our ataxic patients.

RESUMO

Introdução: A avaliação clínica de pacientes atáxicos requer instrumentos confiáveis. Nosso objetivo foi traduzir, adaptar culturalmente e validar a International Cooperative Ataxia Rating Scale (ICARS) para a língua portuguesa do Brasil.

Métodos: As etapas foram tradução, síntese das traduções, retrotradução, comitê de especialistas, pré-teste e avaliação final. O pré-teste foi realizado com 30 pacientes. Outros 61 pacientes foram avaliados para validade do constructo, consistência interna, confiabilidade intra e interexaminadores e consistência externa.

Resultados: Este estudo mostrou boa validade do constructo e alta consistência interna para o total da escala, exceto para o domínio Oculomotor (alfa de Cronbach = 0.316, CCIintra = 82.4% e CCIinter = 79.2%). Alta correlação com a Scale for the Assessment and Rating of Ataxia foi observada. Nós encontramos boa concordância intraexaminador e relativa discordância interexaminadores, com exceção dos domínios postura e marcha.

Conclusão: Esta versão da ICARS está adaptada para a cultura brasileira e pode ser usada em pacientes com ataxia.

Keywords:

Spinocerebellar ataxias - translating - validation studies

Palavras-chave:

Ataxias espinocerebelares - tradução - estudos de validação

• References

• 1 Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004 May;3(5):291-304. https://doi.org/10.1016/S1474-4422(04)00737-9
• 2 Akbar U, Ashizawa T. Ataxia. Neurol Clin. 2015 Feb;33(1):225-48. https://doi.org/10.1016/j.ncl.2014.09.004
• 3 Kim JS, Cho JW. Hereditary cerebellar ataxias: a Korean perspective. J Mov Disord. 2015 May;8(2):67-75. https://doi.org/10.14802/jmd.15006
• 4 Depondt C, Donatello S, Rai M, Wang FC, Manto M, Simonis N et al. MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA 43). Neurol Genet. 2016 Oct;2(5):e94. https://doi.org/10.1212/NXG.20180098201800980094
• 5 Sun YM, Lu C, Wu ZY. Spinocerebellar ataxia: relationship between phenotype and genotype: a review. Clin Genet. 2016 Oct;90(4):305-14. https://doi.org/10.1111/cge.12808
• 6 Nibbeling EA, Duarri A, Verschuuren-Bemelmans CC, Fokkens MR, Karjalainen JM, Smeets CJ et al. Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia. Brain. 2017 Nov;140(11):2860-78. https://doi.org/10.1093/brain/awx251
• 7 Watson LM, Bamber E, Schnekenberg RP, Williams J, Bettencourt C, Lickiss J et al. Dominant Mutations in GRM1 cause spinocerebellar ataxia type 44. Am J Hum Genet. 2017 Nov;101(5):866. https://doi.org/10.1016/j.ajhg.2017.10.008
• 8 Pedroso JL, de Resende Pinto WB, de Souza PV, Andriotti C, Stavale JN, Barsottini OG. Anterior horn degeneration in Machado-Joseph disease. J Neurol Sci. 2016 Sep;368:290-1. https://doi.org/10.1016/j.jns.2016.07.037
• 9 Sarro L, Nanetti L, Castaldo A, Mariotti C. Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research. Expert Rev Neurother. 2017 Sep;17(9):919-31. https://doi.org/10.1080/14737175.2017.1364628
• 10 Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010 Apr;68(2):228-30. https://doi.org/10.1590/S0004-282X2010000200014
• 11 Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997 Feb;145(2):205-11. https://doi.org/10.1016/S0022-510X(96)00231-6
• 12 Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993 Dec;46(12):1417-32. https://doi.org/10.1016/0895-4356(93)90142-N
• 13 Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000 Dec;25(24):3186-91. https://doi.org/10.1097/00007632-200012150-00014
• 14 Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 2011 Jun;2:53-5. https://doi.org/10.5116/ijme.4dfb.8dfd
• 15 Kirkwood BR, Sterne JA. Essential medical statistics. 2nd ed. Massachusetts: Blackwell Science; 2006.
• 16 Strauss ME, Smith GT. Construct validity: advances in theory and methodology. Annu Rev Clin Psychol. 2009;5(1):1-25. https://doi.org/10.1146/annurev.clinpsy.032408.153639
• 17 Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003 Aug;56(8):730-5. https://doi.org/10.1016/S0895-4356(03)00084-2
• 18 Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, Boesch S, Bonato S, Fancellu R et al. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord. 2006 May;21(5):699-704. https://doi.org/10.1002/mds.20781
• 19 Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1986.
• 20 Vieira S. Bio estatística: tópicos avançados. 2nd ed. Rio de Janeiro: Campus; 2004.
• 21 Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32(3):307-17. https://doi.org/10.2307/2987937
• 22 Hirata VN, Camey SV. Análise de concordância entre métodos de Bland-Altman. Rev HCPA. 2009;29(3):261-88.
• 23 Tison F, Yekhlef F, Balestre E, Chrysostome V, Quinn N, Wenning GK et al. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy. Mov Disord. 2002 Nov;17(6):1248-54. https://doi.org/10.1002/mds.10290
• 24 Storey E, Tuck K, Hester R, Hughes A, Churchyard A. Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS). Mov Disord. 2004 Feb;19(2):190-2. https://doi.org/10.1002/mds.10657
• 25 Cano SJ, Hobart JC, Hart PE, Korlipara LV, Schapira AH, Cooper JM. International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia? Mov Disord. 2005 Dec;20(12):1585-91. https://doi.org/10.1002/mds.20651
• 26 Schoch B, Regel JP, Frings M, Gerwig M, Maschke M, Neuhäuser M et al. Reliability and validity of ICARS in focal cerebellar lesions. Mov Disord. 2007 Nov;22(15):2162-9. https://doi.org/10.1002/mds.21543
• 27 Yabe I, Matsushima M, Soma H, Basri R, Sasaki H. Usefulness of the Scale for Assessment and Rating of Ataxia (SARA). J Neurol Sci. 2008 Mar;266(1-2):164-6. https://doi.org/10.1016/j.jns.2007.09.021
• 28 Santos ME. Contenças TS, Santos TMS, Silva EC, Antunes GL. Tradução e adaptaçãoo cultural da escala ICARS-BR na língua portuguesa do Brasil. J Health Sci Inst. 2017;35(1):44-8.